Crossmark

Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2018-000591

Published Online: 2019-02-13

Published Print: 2019-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Kotwal, Anupam

Haddox, Candace

Block, Matthew

Kudva, Yogish C https://orcid.org/0000-0002-4500-8546
Funding

Funding for this research was provided by:

Landow gift through the Center for Immunology and Immune Therapies

CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (UL1 TR002377)